8 - Therapy Observational Designs Flashcards

1
Q

What is the hierarchy of observational designs? (ie after RCT, within the observational category)

A
  1. prospective cohort
  2. prospective cohort w historical controls
  3. retrospective cohort
  4. case-control
  5. case series
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what does a prospective cohort study look like? describe it.

A
  • the only difference btw RCT is that there is no randomization now (people are either self-selected or have been selected into the the groups)
  • now that there is no randomization, allocation concealment goes away (selection bias increases)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what do you look at in a prospective cohort study if you are worried about selection bias?

A
  • look at the tables that describe the 2 groups
  • if there is a big difference btw the 2 groups, could be due to a selection bias causing the outcome
  • physicians should know what values prognostically should balance
  • basically make sure groups are balanced
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what does statistical analysis look like for a prospective cohort study? - what is the term called? what do we like to see?

A
  • same as it would as for an RCT except:
  • must adjust for confounders that might not be randomly allocated
  • so if something is done to these random groups on purpose, dont control for them but if they might be random, we would want to adjust for them
  • called adjusted or stratefied analysis
  • we like to see consistency btw the 2 models (slide 8), if very inconsistent it would mean differences are potentially due to differences btw groups!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what does a prospective cohort with historical control look like? describe

A
  • one treatment group receives the intervention prospectively and another treatment group had received it in the past (the control group)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are we missing in a prospective cohort w historical control study?

A
  • we are missing randomization as well as some control (bc for data in the historical group, we do not make the decisions about data collection etc)
  • dealing with selection bias and also problems to do with this historical data (ie were all criteria, co-interventions etc the same?)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

describe a retrospective cohort study

A
  • again a sample is not randomly allocated to Tx or Ct group

- this time the question is coming after the data has already been collected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what problems do we face with a retrospective cohort study?

A
  • same problems as w historical study (no randomization and relying on others’ data again)
  • is there accurate standardized charting? similar protocol? similar outcomes?
  • completeness status threatens validity of any conclusions you will try and make from this data (worry a lot about applicability due to lots of lost data)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what advantages do we face with a retrospective cohort study?

A
  • advantage: usually gives a large database, ie from a network of clinicians (so large data gives us great precision, but worry about validity of participants included/ whether data was collected well enough to not introduce a bias)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe a case control study

A
  • selecting the cases/controls based on outcome rather than looking at people who received tx/ct first then looking at outcome (backwards)
  • look backwards in time and try to compare the proportion of people who had the outcome and received the tx to the proportion who didn’t have the outcome and received the tx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

who is the case and who is the control in a case control study

A

the person who has had the outcome is the case and the person who hasn’t is the control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the disadvantages to case control studies?

A
  • previous concerns (no randomization and historical data collected)
  • also we now have serious concern about causation (can’t show that one thing happened before the other)
  • also only know the prevalence (not the incidence)
  • no idea whether the sample is a good representation of the population or not
  • no idea the size of the population we would have had to come across to get the n patients (can’t calculate anything that requires incidence!)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

describe selection of incident cases (disease-positive) for case control studies

A
  • incident cases are preferred but refers to “at time of diagnosis” not necessarily onset of disease
  • so treatment could have occurred before onset of outcome or behaviour could have changed as a result of symptoms that occurred before diagnosis
  • temporal relationships = difficult to have
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

for case control studies: the greater the time between the onset and diagnosis ___

A

the more difficult it is to differentiate btw factors that were present before outcome and those that appeared after outcome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe selection of cases for non-incident (prevalent) cases in case control studies

A
  • these are cases where people die or are cured quickly
  • these may under represent those who die quickly or who are cured quickly
  • potential for bias is too great (we don’t want to include this type of study!)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe main points for selection of control in case control studies

A
  • eligibility must be equally applied to cases and controls
  • unbiased selection of individuals who would have been included if they had developed the disease (ie random sample from same population, person seeking medical care from same institution, but unrelated condition, person from a similar setting etc)
17
Q

in a case control study describe 2 cases where a person cannot be a control

A
  • cannot be a control if the person has no chance of ever receiving the tx (ie women being ct for prostate cancer imaging technique) -
  • cannot be a control if a person has a condition where the treatment is the same - this would underestimate our results!
18
Q

you cannot be a control if a person has a condition where the treatment is the same - how does this effect the OR?

A
  • if the ct group is over-represented with treated persons, OR will be underestimated
  • if the ct group is under-represented with treated persons, OR will be overestimated
19
Q

describe a case series study

A
  • aka before/after study
  • there is no control group
  • intervention may work but unsure whether it works better than some comparison (ie nothing or usual care)
  • have sample, do something too them, then see what happens after
  • this is a 1-group study (whereas other studies have 2 groups)
  • prospective or retrospective (prospective better)
  • look at slide 28
20
Q

do we include demographic data for case series studies?

A
  • yes bc people reading the study still want to see whether it will apply to patients they come across
  • most importantly, you can see whether they have changed and whether this is representative of a good change
21
Q

what are concerns with case series studies?

A
  • same as all studies above it plus now there is no control group!
22
Q

check out summary slide

A

slide 29

23
Q

what is strength of association?

A
  • how big is the treatment effect
  • ie big treatment effect = wearing a parachute or not when jumping out of a plane
  • more likely to be causation
24
Q

what is consistency?

A
  • especially among studies of higher quality

- how similar are effect sizes and how over laping are the confidence intervals

25
Q

what is temporal sequence?

A
  • from prospective studies
  • if we can show whether people are disease free and then we did something to them and then they had the outcome we were looking for, that’s helping us with out temporal sequence
26
Q

what is gradient?

A
  • by dose or during exposure
  • if we can show a dose-response that’s evidence for cause (saw this when looking at frequency of debrievement article – healing happened faster the closer together this occurred)
27
Q

what is sense?

A
  • from epidemiology, biology, and analogy

- basically does it make sense

28
Q

what are the evidence(s) to assess claims of causation? (6)

A
  • evidence from the hierarchy of research designs
  • strength of association
  • consistency
  • temporal sequence
  • gradient
  • sense